Page 40 - ARNM-2-4
P. 40

Advances in Radiotherapy
            & Nuclear Medicine                                                       3D-PT-assisted CT-guided  I RSI
                                                                                                        125


               non-coplanar template in peripheral lung cancer. J Contemp   precision   125 I seed implantation.  J  Cancer Res Ther.
               Brachytherapy. 2019;11(2):169-173.                 2016;12(Supplement):C159-C165.
               doi: 10.5114/jcb.2019.84503                        doi: 10.4103/0973-1482.200607
            37.  Rembowska AME, Cook M, Hoskin PJ, Mahdevan A. The   43.  Li L, Yang J, Li X,  et al. (125)I seed permanent
               stepping source dosimetry system as an extension of the   implantation as a palliative treatment for stage III and IV
               manchester system. Radiother Oncol. 1996;39(39):25-25.  hypopharyngeal carcinoma.  Clin Exp Otorhinolaryngol.
               doi: 10.1016/0167-8140(96)87899-6                  2016;9(3):185-191.
            38.  Huang MW, Zhang JG, Zheng L, Liu SM, Yu GY. Accuracy      doi: 10.21053/ceo.2015.00213
               evaluation of a 3D-printed individual template for needle   44.  Jiang Y, Zhen P, Dai J, et al. Long-term safety and efficacy
               guidance in head and neck brachytherapy.  J  Radiat  Res.   of CT-guided I 125 radioactive seed implantation as a
               2016;57(6):662-667.                                salvage therapy for recurrent head and neck squamous
               doi: 10.1093/jrr/rrw033                            carcinoma: A multicenter retrospective study. Front Oncol.
                                                                  2021;11:645077.
            39.  Zhang HT, Di XM, Yu HM, et al. Dose comparison between
               pre and post operation of  I seeds implantation guided by 3D      doi: 10.3389/fonc.2021.645077
                                 125
               print template. Zhonghua Yi Xue Za Zhi. 2016;96(9):712-715.  45.  Zhang Y, Liang Y, Liu Z, Zhang H, Gao Z, Wang J. Efficacy of
                                                                           125
               doi: 10.3760/cma.j.issn.0376-2491.2016.09.010      radioactive  I seed implantation in treating inoperable or
                                                                  refused operation head and neck cancers. J Cancer Res Ther.
            40.  Liang Y, Wang Z, Zhang H, et al. Three-dimensional-printed   2024;20(2):642-650.
               individual template-guided   125 I seed implantation for the
               cervical lymph node metastasis: A dosimetric and security      doi: 10.4103/jcrt.jcrt_1891_23
               study. J Cancer Res Ther. 2018;14(1):30-35.     46.  Li Y, Jiang Y, Wang J. Safety and efficacy of CT-guided
               doi: 10.4103/jcrt.JCRT_619_17                      radioactive iodine-125 seed implantation as a salvage
                                                                  treatment for recurrent head and neck cancer after two or
            41.  Sun HT, Jiang YL, Ji Z,  et al. 3D printing non-coplanar   more courses of radiotherapy. Radiat Oncol. 2023;18(1):73.
               template-assisted 125-iodine seed implantation for thorax
               movement tumor: Individual template design method.      doi: 10.1186/s13014-023-02254-z
               Zhonghua Yi Xue Za Zhi. 2019;99(47):3699-3702.
                                                               47.  Jiang YL, Meng N, Wang JJ,  et al. CT-guided iodine-125
               doi: 10.3760/cma.j.issn.0376-2491.2019.47.005      seed permanent implantation for recurrent head and neck
                                                                  cancers. Radiat Oncol. 2010;5:68.
            42.  Hongtao Z, Xuemin D, Huimin Y,  et al. Dosimetry
               study  of  three-dimensional  print  template-guided     doi: 10.1186/1748-717X-5-68



































            Volume 2 Issue 4 (2024)                         13                             doi: 10.36922/arnm.4212
   35   36   37   38   39   40   41   42   43   44   45